Your browser doesn't support javascript.
loading
EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care.
Hellings, P W; Lau, S; Scadding, G K; Bjermer, L; Backer, V; Chaker, A M; Conti, D M; De Corso, E; Diamant, Z; Djukanovic, R; Fokkens, W; Gevaert, P; Gray, C L; Han, J K; Heaney, L G; Hoffmann, H J; Jesenak, M; Johansen, P; Kumaran, M S; McDonald, M; Melén, E; Mullol, J; Reitsma, S; Ryan, D; Scadding, G; Schmid-Grendelmeier, P; Teeling, T; Odemyr, M; Wahn, U.
Affiliation
  • Hellings PW; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals, Leuven, Belgium.
  • Lau S; Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium.
  • Scadding GK; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin, Berlin, Germany.
  • Bjermer L; Department of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom.
  • Backer V; Division of Immunity and Infection, University College, London, United Kingdom.
  • Chaker AM; Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
  • Conti DM; Department of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • De Corso E; Department of Otorhinolaryngology and Center for Allergy and Environment (ZAUM), TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Diamant Z; The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium.
  • Djukanovic R; Otolaryngology Head and Neck Surgery, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
  • Fokkens W; Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
  • Gevaert P; Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
  • Gray CL; Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Han JK; Dept of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.
  • Heaney LG; NIHR Southampton Biomedical Research Centre, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Hoffmann HJ; Department of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, Netherlands.
  • Jesenak M; Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium.
  • Johansen P; Division of Allergy, Department of Paediatrics and Child Health, University of Cape Town, Rondebosch, South Africa.
  • Kumaran MS; Specialist Allergist, Kidsallergy Centre, Cape Town, South Africa.
  • McDonald M; Department of Otolaryngology & Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, United States.
  • Melén E; Wellcome-Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast, United Kingdom.
  • Mullol J; Department of Clinical Medicine, University of Aarhus, Aarhus, Denmark.
  • Reitsma S; Department of Pulmonology and Phthisiology, Department of Pediatrics, Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovakia.
  • Ryan D; Department of Dermatology, University of Zurich, Zurich, Switzerland.
  • Scadding G; Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Schmid-Grendelmeier P; Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Teeling T; Mediclinic Sandton, Johannesburg, South Africa.
  • Odemyr M; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet and Sachs' Children and Youth Hospital, Stockholm, Sweden.
  • Wahn U; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, FRCB-IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.
Front Allergy ; 4: 1236977, 2023.
Article in En | MEDLINE | ID: mdl-37577332
ABSTRACT
In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an evidence-supported platform to introduce innovation and education in healthcare leading to optimal patient care, bridging the gap between latest scientific evidence and daily practice. Aligned with the mission of improving health care, the expert panels of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS) & European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergen immunotherapy (AIT) and paediatrics have proposed and elaborated a variety of activities that correspond to major unmet needs in the allergy and respiratory field. The current report provides a concise overview of the achievements, ambitions, and action plan of EUFOREA for the future, allowing all stakeholders in the allergy and respiratory field to be up-dated and inspired to join forces in Europe and beyond.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Front Allergy Year: 2023 Document type: Article Affiliation country: Bélgica
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Front Allergy Year: 2023 Document type: Article Affiliation country: Bélgica